Journal article
Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer
Abstract
Background:Patients with platinum-sensitive recurrent ovarian cancer are a heterogeneous group, and it is not possible to accurately predict the progression-free survival (PFS) in these patients. We developed and validated a nomogram to help improve prediction of PFS in patients treated with platinum-based chemotherapy.Methods:The nomogram was developed in a training cohort (n=955) from the CALYPSO trial and validated in the AGO-OVAR 2.5 Study …
Authors
Lee CK; Simes RJ; Brown C; Lord S; Wagner U; Plante M; Vergote I; Pisano C; Parma G; Burges A
Journal
British Journal of Cancer, Vol. 105, No. 8, pp. 1144–1150
Publisher
Springer Nature
Publication Date
10 2011
DOI
10.1038/bjc.2011.364
ISSN
0007-0920